Displaying drugs 4851 - 4875 of 5888 in total
Tuvusertib
Investigational
5'-Fluoro-5'-Deoxyadenosine
Experimental
Fluprednisolone acetate
Experimental
Firolimogene autotemcel
Investigational
Tilpisertib fosmecarbil
Investigational
Flurbiprofen Methyl Ester
Experimental
Methanesulfonyl Fluoride
Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational
DDP-225 free base anhydrous
Investigational
Amineptine
The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until 2005.
Illicit
Withdrawn
Chrysin
Experimental
trans-urocanic acid
Experimental
CLZ-2002
CLZ-2002 consists of allogeneic mesenchymal stem cells derived neuronal regeneration-promoting cells.
Investigational
L-tyrosinamide
Experimental
3-nitro-L-tyrosine
Experimental
2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational
Subasumstat
Subasumstat is under investigation in clinical trial NCT03648372 (A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)).
Investigational
Ethyl Dimethyl Ammonio Propane Sulfonate
Experimental
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE
Experimental
Izencitinib
Izencitinib is under investigation in clinical trial NCT03920254 (TD-1473 Long-term Safety (LTS) Ulcerative Colitis (UC) Study).
Investigational
LH-708
Investigational
AGF-94
Investigational
Displaying drugs 4851 - 4875 of 5888 in total